These findings shed light on the complex control mechanisms for how the two primary steroid converting HSD17 enzymes are regulated in breast cancer cell lines, and will hopefully open up for further lines of study which could lead to therapeutic interventions. Here, HSD17B2 is linked to breast cancer.